Eli Lilly & Co.’s treatment for Alzheimer’s disease works in at least some patients, according to a US advisory panel.
Lilly Alzheimer’s Drug Seen Effective by FDA Advisory PanelEurope in Talks to Keep Russia-Ukraine Gas Pipeline FlowingLatin America’s Patria Eyes Piece of Saudi Crown Prince’s VisionElliott Disrupts CEOs’ Summer Plans With $400 Billion in New TargetsUS Oil Output To Fall Next Year Unless Rig Counts Rise, Key Energy Investor SaysDeutsche Bank Says the Low-Default Era of Past 20 Years Is OverEurope in Talks to Keep Russia-Ukraine Gas Pipeline FlowingUS Imposes Fresh Sanctions Targeting Houthi Oil...
Here's how to fix it, according to RBCHere are the key takeaways from Bank of Canada's rate-cut decisionTraders gird for weaker Canadian dollar as first rate cut eyedRail strike could cost manufacturers millions, industry saysOrban Ekes Out Win in Hungary’s EU Vote as Challenger SurgesVon der Leyen Faces Tricky Balancing Act to Seal Second EU TermEmerging Currencies Drop as EU Elections Add to Political RisksIndia Reappoints Nirmala Sitharaman as Finance MinisterLe Pen’s Party Seen...
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA Staff Proposes Narrow Approval for Lilly’s Alzheimer’s DrugUS drug regulatory staffers are considering a more targeted approval for Eli Lilly & Co.’s experimental Alzheimer’s disease treatment than the company wants, potentially limiting the market for a would-be blockbuster.
Read more »
Eli Lilly’s Obesity Drug Crunch Shows Signs of Easing in JapanEli Lilly & Co.’s hefty investment in expanding production capacity for its popular weight-loss and diabetes drugs is starting to pay off in Japan, allowing the company to lift shipment controls it imposed in the country last year.
Read more »
Britain Poised to Offer Eli Lilly’s Weight-Loss Drug to PatientsEli Lilly & Co.’s Mounjaro is being recommended for weight loss for some UK patients with obesity, in draft guidance that could see the National Health Service offer a rival drug to Novo Nordisk A/S’s hit treatment Wegovy.
Read more »
Eli Lilly commits $5.3B to up weight-loss drug productionEli Lilly and Company (LLY) announced today that it has committed more than $5.3 billion to its Lebanon, Indiana, manufacturing site, more than doubling its ...
Read more »
Lilly invests over US$5 billion to boost weight-loss drug supplyEli Lilly & Co. will spend US$5.3 billion to boost production of a key ingredient in its weight-loss and diabetes shots after the treatments’ explosive popularity led to shortages.
Read more »
Lilly Invests Over $5 Billion to Boost Weight-Loss Drug SupplyEli Lilly & Co. will spend $5.3 billion to boost production of a key ingredient in its weight-loss and diabetes shots after the treatments’ explosive popularity led to shortages.
Read more »